Form 4: Zimmer Biomet Director Reports Phantom Stock Units

Sentiment:

Insider Transaction Report


Michael J. Farrell, a Director at Zimmer Biomet Holdings, Inc., reported transactions involving phantom stock units under the company's Deferred Compensation Plan for Non-Employee Directors.

Summary

  • Michael J. Farrell, a Director of Zimmer Biomet Holdings, Inc., has filed a Form 4 detailing transactions related to phantom stock units.
  • These units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.
  • The phantom stock units are to be settled in cash within sixty days after the reporting person ceases to be a Director.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents a routine disclosure of insider compensation and does not indicate significant new financial performance or strategic shifts.

Future Outlook

The filing indicates that the phantom stock units will be settled in cash within sixty days following the cessation of the reporting person's service as a Director.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions, providing transparency into the holdings and activities of company directors and officers. This specific filing pertains to compensation structures common in the medical device industry.

Related Party Transactions

  • Transaction involves phantom stock units accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors, which is a related party transaction between the company and its director.

Stakeholder Impact

  • Shareholders: Increased transparency regarding director compensation and potential future cash outflows from the company.
  • Employees: No direct impact, as this relates to non-employee director compensation.
  • Management: Standard reporting requirement, no direct impact on operational management.

Next Steps

  • Settlement of phantom stock units in cash upon cessation of directorship.

Key Dates

DateDescription
06/30/2026Earliest transaction date and settlement date for phantom stock units.
07/02/2026Date of filing signature.

Keywords

Zimmer Biomet Holdings, Form 4, SEC Filing, Director, Phantom Stock Units, Deferred Compensation Plan, Beneficial Ownership

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.